Quality and Analytical Testing
How Do You Verify a Peptide Supplier?
Quick answer
Verify a peptide supplier in four steps: confirm the legal entity and address, request the COA with its chromatogram and mass spectrum for a specific lot, test whether they can re-test that lot and explain deviations, and compare the documents for internal consistency. A manufacturer can describe the batch it made. A reseller who never saw the batch answers every technical question with a brochure.
Key facts at a glance
| Entity check | Registered name, address and bank beneficiary should match on website, invoice and COA |
|---|---|
| Document set | COA, HPLC chromatogram, mass spectrum, SDS and specification sheet |
| Traceability | Lot number tied to a synthesis, purification and lyophilisation record |
| Re-testing | Retained samples from the same lot available for independent analysis |
| System evidence | Deviation, nonconformance and change control records, not only certificates |
| Red flag | A purity claim with no method, or "GMP certified" with no certificate scope |
Confirm the legal entity before you read any data
A supplier is a legal entity before it is a laboratory. Start with the company registration name, the registered address and the bank beneficiary. Those three should be identical across the website, the quotation, the invoice and the certificate of analysis. A mismatch is not automatically fraud, but it is the single most common pattern behind fabricated suppliers: a trading name on the website, a different entity on the invoice, and a different factory address on the COA.
Trading companies are legitimate and common in this industry. The question is disclosure. Ask directly who performs the synthesis and at which site, and whether the supplier controls the specification and holds the analytical data. A trader who says "our partner facility in Changsha" and can name the site, the contact and the release laboratory is workable. A trader who becomes vague at that question is a broker between you and someone they cannot audit. Either way, the entity that signs the COA should be the entity you can hold to a quality agreement.
Documents a supplier should produce on request
- Certificate of analysis for the specific lot, with methods, specifications, results and a release signature.
- HPLC chromatogram showing the gradient, wavelength, integration table and system suitability.
- Mass spectrum with charge states or MALDI adducts annotated, plus the deconvoluted mass and ppm error.
- Safety data sheet in GHS format, covering handling, storage and disposal.
- Specification sheet stating the release limits for purity, water, counter-ion and appearance.
- Batch record summary or certificate of manufacture, available under a confidentiality agreement.
- Quality manual or certificate scope, so you can see what the certification actually covers.
- Deviation and nonconformance summary for the lot, which almost nobody requests and almost everybody should.
Request the documents for the lot you will receive, not a generic example. A supplier who sends the same sample COA to every enquiry is showing you marketing material, and the first question worth asking is whether the lot number on it can be found in their records.
Ask whether they can re-test your batch
Re-testing is the most revealing single question in supplier verification. Phrase it concretely: can you pull a retained sample of lot X in three months, run HPLC and mass spectrometry again, and send me the new data? A manufacturer with a retention programme can do this without difficulty. A reseller has to go back to the factory, and a fabricator has nothing to pull.
The same logic applies before you order. Ask for a small sample from the lot you are considering, split it, test half in-house or at a third party, and keep the other half sealed. If the bulk arrives and the data does not match, the retained half is your evidence. This costs a few hundred dollars on a large order and settles arguments that otherwise run for weeks. It also changes the conversation: suppliers who know the sample will be tested tend to send the batch they are proud of.
Audit trail, batch records and nonconformance handling
A traceable lot links six things: the sequence order, the resin and amino acid lots used, the cleavage and purification fractions that were pooled, the lyophilisation cycle, the fill weight, and the analytical results that led to release. Any supplier can show the first and last of those. The middle four are what tell you whether the material was made deliberately or assembled from whatever was available.
Nonconformance handling is the other half of the audit trail. Peptide synthesis fails routinely: a coupling is incomplete, a sequence truncates, a purification pool misses the purity specification. A supplier that reports no deviations across thousands of batches is not recording them, which means the release decision is undocumented. Ask to see one anonymised deviation report and its corrective action. The quality of that document predicts more about a supplier than any certificate on the website.
Retention samples and stability programmes
Retention samples are the physical memory of a batch. The usual practice is to keep enough material for at least two full re-tests, stored under the labelled conditions, for the retest period plus a margin. Without retention samples, a complaint about purity six months after delivery cannot be investigated: nobody can distinguish a manufacturing problem from a storage problem, and the supplier will default to blaming the customer.
Stability data is the companion evidence. Asking for it does not require a formal ICH package for a research peptide, but there should be some structured data: purity and water content at T=0, one month, three months and six months for representative sequences. A supplier who has never measured stability can still recommend storage, but the retest date on the COA is then a convention rather than a finding. The study design is described in how peptide stability is tested.
Third-party testing: what it proves and what it does not
An independent laboratory answers one question well: what is in this vial? It can confirm HPLC purity, mass identity and water content on a sealed sample, ideally under a chain of custody and at a laboratory accredited to ISO/IEC 17025. That is strong evidence about the material and useful leverage if a dispute arises.
It does not prove who made the peptide, whether the documentation is genuine, or whether the next lot will match. Nor should a single divergent result be treated as proof of fraud: differences in column, gradient and integration threshold routinely move a purity figure by one or two points. Send the third-party method to the supplier and ask them to explain the difference on the chromatogram. A technical answer is a good sign; a defensive one is information too. For routine incoming checks, MOL Changes supports re-testing through peptide testing.
Red flags that survive a follow-up question
| Red flag | Why it matters |
|---|---|
| COA with no lot number | The document cannot be tied to any physical batch, so nothing on it can be audited. |
| Purity quoted without a method | The figure is not reproducible and may come from a screening run that never saw the impurities. |
| Different entities on website, invoice and COA | Typical of a broker chain, and it leaves no single party accountable. |
| Mass reported only as a whole number | Suggests the value was calculated from the sequence rather than measured on the lot. |
| Refusal to provide a retention sample or re-test | Implies no traceable stock and no ability to investigate a complaint. |
| "GMP certified" or "FDA approved" with no certificate or scope | Both phrases have defined meanings; without a document they are misrepresentation. |
| Price far below the market at small scale | At 10 mg, synthesis and purification costs do not disappear; something in the package is being omitted. |
| Technical questions answered only with brochures | Suggests no chemist is in the loop and no batch data is accessible to the sales team. |
One red flag justifies a question. Two or three justify a sample test. Five is a decision already made. The COA checklist covers the document side in more detail, and our quality page describes what MOL Changes will and will not claim.
Frequently asked questions
How do I know if a peptide supplier is legitimate?
Check that one legal entity appears consistently on the website, quotation, invoice and COA, then ask for the chromatogram and mass spectrum for the exact lot you will receive. A supplier that manufactures can produce batch-level data and retained samples. A broker can often supply material but should disclose who makes it.
Should I buy peptides from a Chinese supplier?
Many legitimate peptide manufacturers operate in China, including MOL Changes in Changsha. Country is not the risk factor; documentation is. Evaluate a Chinese supplier the same way as any other: entity checks, lot-specific data, re-testing, retention samples and a named technical contact who can discuss the synthesis.
What is a peptide supplier audit?
A supplier audit reviews the quality system behind the product: batch records, deviation history, change control, analytical methods, retention samples and training. For a research peptide it can be a documented questionnaire plus a sample test. For clinical supply it becomes an on-site audit with a quality agreement.
Can a reseller be a reliable peptide supplier?
Yes, if the arrangement is transparent. The reseller should name the manufacturing site, pass through lot-specific analytical data, and be able to arrange re-testing or a factory audit. Problems arise when a reseller presents itself as the manufacturer and cannot answer questions about the batch.
How often should a peptide supplier be re-qualified?
A common cycle is annual for critical suppliers and every two to three years for routine ones, or sooner after a quality issue, a site change or a specification change. Re-qualification usually means a refreshed questionnaire, a review of deviation history and a sample test on a current lot.
What should I do if a delivered peptide fails my testing?
Stop and preserve the sample and packaging, then ask the supplier for the lot chromatogram and method so the difference can be compared. Send a sealed aliquot to a third party if the disagreement continues. Most discrepancies are method differences, but a genuine failure should trigger a deviation report and a replacement or credit.
Sources and scope
This answer is based on peer-reviewed peptide chemistry and analytical literature, pharmacopoeial requirements (USP <503>, Ph. Eur. 2.2.29 and 2.2.46), FDA and EMA guidance on peptide drug substances, and MOL Changes in-house synthesis and testing data. Product statements describe research-grade peptides supplied for laboratory and manufacturing use. They are not medical advice and are not a substitute for clinical judgement.
